Raphanus sativus L. (Brassicaceae) is widely consumed in many different forms worldwide. Its sprouts, in particular, are commonly consumed as a health food. R. sativus sprout has recently been shown to have anti-tumor activity on human colon cancer cells, suggesting that it may have potential use in cancer prevention and treatment. The extent of this anti-tumor activity and its underlying mechanisms, however, remain to be investigated in other types of cancer cells. In this study, we showed that the MeOH extract from R. sativus sprout exhibits significant but variable cytotoxic effects on human lung adenocarcinoma cells depending on their p53 status. The MeOH extract decreased the viability of p53-deleted human lung cancer cells (H1299 and Calu-6) by inducing apoptosis; this effect, however, did not occur for wild-type p53 cancer cells (A549), for cells expressing a p53 mutant lacking the C terminus (H1264), or for non-tumor fibroblast cells (NIH3T3). Phytochemical analyses of the MeOH extract allowed us to identify and isolate β-sitosterol as a major component of the MeOH extract. Direct treatment with β-sitosterol significantly reduced the viability of Calu-6 cells, suggesting that it may, in part, contribute to R. sativus sprout's anti-tumor activity. This work provides experimental evidence for a novel biological application of R. sativus sprout in treating human lung cancer, and it identifies the main component involved in this effect, further supporting its potential use as a functional food for cancer management.
Cancer is a lethal disease typically caused by mutations that result in uncontrolled cell growth that subsequently invades surrounding tissues; such systemic metastasis is now the second leading cause of death worldwide [1, 2] . Natural products from many species (including microorganisms, marine organisms, and other plants) have proved valuable resources for securing molecular treatments for cancer [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Indeed, many anti-cancer drugs derived from natural products (such as paclitaxel, doxorubicin, and rapamycin) are currently either in clinical use or preclinical evaluation to treat cancer patients [4, 5, 13] . Therefore, screening natural product extracts for anti-cancer activity and then identifying useful compounds is an important avenue of research for cancer prevention and treatment.
Raphanus sativus L. (Brassicaceae), commonly known as radish, is widely consumed around the world [14] . It is one of the Brassica vegetables that contains many compounds that have positive effects in maintaining human health such as vitamins C and E, fiber, carotenoids, polyphenols, and glucosinolates [15, 16] . The first Chinese pharmacopoeia, 'Tang Materia Medica,' reported that R. sativus was used as a traditional herbal medicine for more than 1400 years [17] . All parts of the radish, including leaves, seeds, and roots, have been used for medicinal purposes, such as carminative, diuretic, expectorant, laxative, and digestive treatments [18] . Building upon our group's prior work investigating the biological properties and bioactive constituents of Korean medicinal resources, we examined the seeds of R. sativus, also known as Raphani Semen [17] [18] [19] . In our previous works, we demonstrated that the MeOH extract of Raphani Semen induces anti-tumor and anti-inflammatory effects, and we isolated and identified 4-methylthio-butanyl derivatives, phenylpropanoid sucrosides, and phenolic compounds that are the likely causative agents [17] [18] [19] . Here, we extend this work by investigating the effect of the MeOH extract of R. sativus sprouts on human lung adenocarcinoma cells.
R. sativus sprouts have long been considered a health food, as they contain high levels of protein, minerals, and vitamins [20] , as well as antioxidant glucosinolates, including glucoraphasatin and glucoraphenin [21] . In Korea, in particular, they are consumed in many ways, such as in salads and "Bibimbap," a signature Korean dish. Previous studies have shown that R. sativus sprouts contain glucosinolates [21] , sinapinic acid esters [22] , flavonoids [22] , and anthocyanins [23] . Sinapinic acid esters and several kinds of flavonoids in the sprouts have been shown to possess strong antioxidant activity [22] . Of particular note is a recent study in which 4-methylthio-3-butenyl isothiocyanate was isolated in the extract of R. sativus sprout and shown to inhibit cell proliferation in three human colon carcinoma cell lines (LoVo, HCT-116, and HT-29). Furthermore, this extract was shown to induce apoptotic cell death in those cancer cells in vitro, suggesting that it has excellent potential use in cancer management [15] . The anti-cancer activity of R. sativus sprout, however, must be further validated in other types of cancer in order to assess thoroughly its potential utility for cancer prevention and treatment.
In this study, we measured the effect of the MeOH extract of R. sativus sprout on human lung adenocarcinoma cells and found that it dramatically reduced cell viability by inducing apoptosis depending on p53 status. Additionally, we phytochemically investigated the MeOH extract, which led us to isolate a major component, β-sitosterol. To the best of our knowledge, R. sativus sprout has not previously been shown to have anti-tumor effects against lung cancer. With this work, we characterized the antitumor effects of R. sativus sprout on human lung cancer cells and isolated the main component that is the likely causative agent. Lung cancer has been the leading cause of cancer death in both men and women worldwide for several decades [2, 24] . As such, we evaluated the cytotoxic effect of the MeOH extract of R. sativus sprouts on human lung adenocarcinoma cells ( Figure 1 ). Because chemoresistance in cancer patients has previously been shown to be correlated with p53 status [25, 26] , we also characterized the effect of the MeOH extract on four human non-small cell lung cancer (NSCLC) cell lines with different p53 statuses [27] . Furthermore, we characterized its cytotoxicity against a non-tumor cell line, NIH3T3, in order to determine whether this effect specifically targets cancer cells.
Treatment with the MeOH extract of R. sativus sprouts dramatically reduced cell viability in human lung cancer cells null for p53 expression (Calu-6 and H1299) in a dose-dependent manner (IC 50 values ranged from 394.4 ± 3.9 to 405.9 ± 3.7 μg/mL - Figure 1A) . Interestingly, however, it failed to induce cytotoxicity in A549 and NIH3T3 cells (which harbor wild-type p53). Further, it failed to exhibit a cytotoxic effect on H1264 cells, which express a p53 mutant that lacks both the nuclear localization signal (NLS) and the oligomerization domain (Figure 1 ). These data suggest that the MeOH extract of R. sativus sprouts induces selective cytotoxicity against human lung cancer cells depending on p53 status. Because p53 plays several important regulatory roles in the cytoplasm and in the nucleus [28] , this suggests that the cytoplasmic function of p53 confers resistance in H1264 cells against the MeOH extract of R. sativus sprouts. Further studies will be necessary to determine whether other p53 mutations can similarly reverse the anti-tumor activity of the MeOH extract of R. sativus sprouts on human lung cancer cells.
Upon treatment with the MeOH extract of R. sativus sprouts, Calu-6 and H1299 cells exhibited significant morphological changes, including cell shrinkage and rounding up, membrane blebbing, and detachment from the substratum; these changes are known to be typical features of apoptotic cell death ( Figure 1B ) [29] . To verify further that the MeOH extract induced apoptosis in human lung cancer cells depending on their p53 status, we assessed cell populations undergoing apoptosis in those cells using TUNEL staining after treating them with the extract at IC 50 doses for 48 hours ( Figure 2 ). As expected, apoptotic cells were significantly increased in Calu-6 and H1299 cells, but not in A549, H1264, and NIH3T3 cells, implying that the MeOH extract of R. sativus sprouts exhibits anti-tumor activity by inducing apoptosis in the absence of p53 expression. Additionally, it appears that only cytoplasmic p53 is required to reverse the MeOH extract-induced apoptotic activity; further studies are needed to characterize fully the underlying molecular mechanism of this effect.
The MeOH extract of R. sativus sprouts was fractionated, yielding CH 2 Cl 2 soluble and EtOAc fractions. Phytochemical investigation of the consolidated CH 2 Cl 2 and EtOAc soluble fractions with column chromatography revealed the presence of β-sitosterol as a main component; this compound was identified by comparing spectroscopic data, including 1 H and 13 C NMR, with previously reported values and LC/MS analysis. β-Sitosterol is a common steroid found in a wide range of plant species and in foods like vegetables, nuts, and salads and it has been shown to have various pharmacological activities (such as antiherpes, anti-inflammatory, cytotoxic, and immunomodulation effects) [30, 31] . β-Sitosterol has also been reported to inhibit the growth of human colon cancer cells and to induce apoptosis in human prostate cancer cells [32, 33] . After identifying it at a high level in the MeOH extract, we next examined its direct impact on the viability and proliferation of human lung cancer cells (Figure 3) . After treating Calu-6 cells with β-sitosterol, we found a significant and dose-dependent decrease in cell viability. Additionally, the cells exhibited the typical morphology of apoptotic cells (Figure 3) . Although the proliferation of H1299 cells also decreased slightly, but statistically significantly, upon β-sitosterol treatment, this effect was not dose-dependent. Cell proliferation in A549 and H1264, where the MeOH extract of R. sativus sprouts did not exhibit any cytotoxicity, were also reduced at a similar level to that of H1299 cells after β-sitosterol treatment. Together with the measured IC 50 values of the MeOH extract in H1299 and Calu-6 cells, these observations suggest that the distinct effect of β-sitosterol on H1299 versus Calu-6 cells is likely due to different cellular and genetic contexts. This work thus suggests that the anti-tumor activity of the MeOH extract of R. sativus sprouts is due, at least in part, to β-sitosterol, although other compounds also are likely to contribute to its cytotoxic activity on human lung cancer cells.
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Experimental

General experimental procedures:
Column chromatography was performed using silica gel 60 (Merck, Darmstadt, Germany; 70-230 mesh and 230-400 mesh). Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AVANCE III 700 NMR spectrometer operating at 700 MHz ( 1 H) and 175 MHz ( 13 C), with chemical shifts measured in ppm (δ) (Bruker). Merck pre-coated silica gel F254 plates and reversed-phase (RP)-18 F254s plates (Merck) were used for thin-layer chromatography (TLC). TLC spots were detected under UV light or by heating after spraying with anisaldehyde-sulfuric acid. Semi-preparative high-performance liquid chromatography (HPLC) was performed using a Shimadzu Prominence HPLC System with SPD-20A/20AV Series Prominence HPLC UV-Vis Detectors.
Sample collection and extraction: R. sativus sprouts, purchased at E-mart, were cultivated and harvested in Garak-dong, Sonpa-gu, Seoul, in October 2015. A voucher specimen (SKK-MOO-2015) was identified by one of the authors (K. H. Kim) and deposited in the herbarium at the School of Pharmacy, Sungkyunkwan University, Suwon, Korea. The air-dried sprouts of R. sativus (155 g) were extracted 3 times with 100% MeOH at room temperature. To obtain a crude MeOH extract, the filtered extract was evaporated using a rotavapor. The MeOH extract was then dissolved in 50% dimethyl sulfoxide (DMSO, Sigma, St. Louis, MO, USA), diluted in RPMI-1640 media (WelGENE, Seoul, Korea) and stored at -80 o C until used for treating cells.
Cell lines and culture:
Human lung adenocarcinoma cell lines A549, H1264, H1299, and Calu-6, and immortalized mouse embryonic fibroblasts, NIH3T3, were maintained in RPMI-1640 and DMEM media (WelGENE), respectively, both supplanted with 10% FBS (Gemini Bio-Products, West Sacramento, CA, USA), 2 mM L-glutamine, 50 U/mL penicillin, and 50 μg/mL streptomycin (WelGENE) at 37 o C in a humidified atmosphere of 5% CO 2 . o C for 25 min, permeabilized in 0.2 % Triton X-100 (Sigma) at room temperature for 5 min, and then incubated in equilibration buffer at room temperature for 10 min. The cells were subsequently incubated with both fluoresceinated rdNTPs and terminal deoxynucleotidyl transferase at 37°C for 60 min in a humidified chamber; the reaction was then terminated by incubation in 2SSC buffer at room temperature for 15 min. After counterstaining with 1 μg/mL Hoechst dye (Sigma) in order to visualize cell nuclei, the coverslips were mounted on slides with 90% glycerol (Sigma) in PBS and examined under a fluorescence microscope (Carl Zeiss, Jena, Germany). The percentage of apoptotic cells was determined as the number of cells positive for TUNEL staining divided by the total number of cells counted in 6 randomly selected high-power fields (400) on each slide. More than 200 cells were counted per slide.
Cell viability analysis:
Statistical analysis: Statistical differences were assessed between cells treated with either MeOH extract of R. sativus sprout or β-sitosterol and their respective vehicle controls using unpaired Student's two-tailed t test. Data are presented as mean ± SEM, and p values less than 0.05 were considered statistically significant.
Isolation of main constituents:
The crude extract (2 g) was fractionated by sequential liquid-liquid partitioning of H 2 O (200 mL) with dichloromethane (CH 2 Cl 2 , 200 mL) and EtOAc (200 mL). Each layer was then consolidated to yield fraction A (332 mg) by TLC analysis. Fraction A was subjected to open silica gel column chromatography using a gradient solvent system of CH 2 Cl 2 -MeOH (200:1, 100:1, 30:1, 10:1, 5:1 and 2:1) to yield 6 fractions (A1-A6) by TLC analysis. Among these sub-fractions, A3 (48.3 mg) was purified by semi-preparative reversed-phase HPLC (87% MeOH) using a Phenomenex Luna HPLC phenyl-hexyl column (250 × 10 mm; flow rate: 2 mL/min) to yield compound 1 (5 mg, t R = 30 min). Compound 1, β-sitosterol, was then dissolved in EtOH and stored at -80 o C until used for treating cells.
